Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Rapamycin and Calcitriol for Facial Angiofibroma in Tuberous Sclerosis
NCT03140449Phase 3Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Sep 2013
- Primary completion
- Nov 2016
- Modality
- Orthosteric Ligands
01
Overview
Phase 3, randomised, double-blind trial of sirolimus and calcitriol in facial angiofibroma (3 arms), sponsored by National Taiwan University Hospital. Primary endpoint: Facial Angiofibroma Severity Index at 36 weeks. Started Sep 2013; status: completed.
02
Drugs
sirolimuscalcitriol
03
Conditions
facial angiofibroma
Beyond the preview
Go deeper on NCT03140449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03140449.